Alerts will be sent to your verified email
Verify Email
SPML
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Speciality Medicines, incorporated in February 2021, is primarily focused on the export, trading, and distribution of pharmaceutical medicines and vaccines. The company is specialized in global supply of all medicinal products and a well-known distributor in the industry for providing quality rich, reliable services.
Speciality Medicines major competitors are Remus Pharmaceutical, Trident Lifeline, Mono Pharmacare.
Market Cap of Speciality Medicines is ₹136 Crs.
While the median market cap of its peers are ₹295 Crs.
Speciality Medicines seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | |||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
